These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30508893)

  • 1. Long-term outcomes of a patient with late-onset multiple acyl-CoA dehydrogenase deficiency caused by novel mutations in ETFDH: A case report.
    Wang J; Wu JC; Yu XE; Han YZ; Yang RM
    Medicine (Baltimore); 2018 Nov; 97(48):e13153. PubMed ID: 30508893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of two ETFDH mutations in a novel case of riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.
    Missaglia S; Tavian D; Moro L; Angelini C
    Lipids Health Dis; 2018 Nov; 17(1):254. PubMed ID: 30424791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significant clinical heterogeneity with similar ETFDH genotype in three Chinese patients with late-onset multiple acyl-CoA dehydrogenase deficiency.
    Fu HX; Liu XY; Wang ZQ; Jin M; Wang DN; He JJ; Lin MT; Wang N
    Neurol Sci; 2016 Jul; 37(7):1099-105. PubMed ID: 27000805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased muscle coenzyme Q10 in riboflavin responsive MADD with ETFDH gene mutations due to secondary mitochondrial proliferation.
    Wen B; Li D; Shan J; Liu S; Li W; Zhao Y; Lin P; Zheng J; Li D; Gong Y; Yan C
    Mol Genet Metab; 2013 Jun; 109(2):154-60. PubMed ID: 23628458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late-onset riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency (MADD): case reports and epidemiology of ETFDH gene mutations.
    Chen W; Zhang Y; Ni Y; Cai S; Zheng X; Mastaglia FL; Wu J
    BMC Neurol; 2019 Dec; 19(1):330. PubMed ID: 31852447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient with multiple acyl-CoA dehydrogenase deficiency disease and ETFDH mutations benefits from riboflavin therapy: a case report.
    Goh LL; Lee Y; Tan ES; Lim JSC; Lim CW; Dalan R
    BMC Med Genomics; 2018 Apr; 11(1):37. PubMed ID: 29615056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ETFDH mutations, CoQ10 levels, and respiratory chain activities in patients with riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.
    Liang WC; Ohkuma A; Hayashi YK; López LC; Hirano M; Nonaka I; Noguchi S; Chen LH; Jong YJ; Nishino I
    Neuromuscul Disord; 2009 Mar; 19(3):212-6. PubMed ID: 19249206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of Riboflavin Responsiveness in Multiple Acyl-CoA Dehydrogenase Deficiency.
    Yıldız Y; Talim B; Haliloglu G; Topaloglu H; Akçören Z; Dursun A; Sivri HS; Coşkun T; Tokatlı A
    Pediatr Neurol; 2019 Oct; 99():69-75. PubMed ID: 31331668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel mutations in ETFDH gene in Chinese patients with riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.
    Law LK; Tang NL; Hui J; Fung SL; Ruiter J; Wanders RJ; Fok TF; Lam CW
    Clin Chim Acta; 2009 Jun; 404(2):95-9. PubMed ID: 19265687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis of 51 unrelated pedigrees with late-onset multiple acyl-CoA dehydrogenation deficiency (MADD) in southern China confirmed the most common ETFDH mutation and high carrier frequency of c.250G>A.
    Wang ZQ; Chen XJ; Murong SX; Wang N; Wu ZY
    J Mol Med (Berl); 2011 Jun; 89(6):569-76. PubMed ID: 21347544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel ETFDH mutation in an adult patient with late-onset riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.
    Chen M; Peng J; Wei W; Wang R; Xu H; Liu H
    Int J Neurosci; 2018 Mar; 128(3):291-294. PubMed ID: 28914566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study on riboflavin responsive multiple acyl-CoA dehydrogenation deficiency due to variants in FLAD1 and ETFDH gene.
    Wen B; Tang R; Tang S; Sun Y; Xu J; Zhao D; Wang T; Yan C
    J Hum Genet; 2024 Apr; 69(3-4):125-131. PubMed ID: 38228875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron-transferring-flavoprotein dehydrogenase (ETFDH) gene.
    Gempel K; Topaloglu H; Talim B; Schneiderat P; Schoser BG; Hans VH; Pálmafy B; Kale G; Tokatli A; Quinzii C; Hirano M; Naini A; DiMauro S; Prokisch H; Lochmüller H; Horvath R
    Brain; 2007 Aug; 130(Pt 8):2037-44. PubMed ID: 17412732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Riboflavin-responsive lipid-storage myopathy caused by ETFDH gene mutations.
    Wen B; Dai T; Li W; Zhao Y; Liu S; Zhang C; Li H; Wu J; Li D; Yan C
    J Neurol Neurosurg Psychiatry; 2010 Feb; 81(2):231-6. PubMed ID: 19758981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial energetic impairment in a patient with late-onset glutaric acidemia Type 2.
    Xiao C; Astiazaran-Symonds E; Basu S; Kisling M; Scaglia F; Chapman KA; Wang Y; Vockley J; Ferreira CR
    Am J Med Genet A; 2020 Oct; 182(10):2426-2431. PubMed ID: 32804429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical, pathological and genetic features and follow-up of 110 patients with late-onset MADD: a single-center retrospective study.
    Wen B; Tang S; Lv X; Li D; Xu J; Olsen RKJ; Zhao Y; Li W; Wang T; Shao K; Zhao D; Yan C
    Hum Mol Genet; 2022 Mar; 31(7):1115-1129. PubMed ID: 34718578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of late-onset riboflavin responsive multiple acyl-CoA dehydrogenase deficiency with novel mutations in ETFDH gene.
    Zhao ZN; Bao MX; Ma GT; Liu XM; Xu WJ; Sun ZW; Chen H; Zhu MJ
    CNS Neurosci Ther; 2012 Nov; 18(11):952-4. PubMed ID: 23106979
    [No Abstract]   [Full Text] [Related]  

  • 18. Multiple acyl-CoA dehydrogenation deficiency as decreased acyl-carnitine profile in serum.
    Wen B; Li D; Li W; Zhao Y; Yan C
    Neurol Sci; 2015 Jun; 36(6):853-9. PubMed ID: 25827849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple acyl-CoA dehydrogenase deficiency (MADD) as a cause of late-onset treatable metabolic disease.
    Béhin A; Acquaviva-Bourdain C; Souvannanorath S; Streichenberger N; Attarian S; Bassez G; Brivet M; Fouilhoux A; Labarre-Villa A; Laquerrière A; Pérard L; Kaminsky P; Pouget J; Rigal O; Vanhulle C; Eymard B; Vianey-Saban C; Laforêt P
    Rev Neurol (Paris); 2016 Mar; 172(3):231-41. PubMed ID: 27038534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compound heterozygous mutations in electron transfer flavoprotein dehydrogenase identified in a young Chinese woman with late-onset glutaric aciduria type II.
    Xue Y; Zhou Y; Zhang K; Li L; Kayoumu A; Chen L; Wang Y; Lu Z
    Lipids Health Dis; 2017 Sep; 16(1):185. PubMed ID: 28950901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.